Group One Trading
IMUX icon

Group One Trading’s Immunic IMUX Stock Holding History

Group One Trading’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23.3K Sell
2,100
-16,810
-89% -$151K ﹤0.01% 5849
2025
Q4 		$101K Sell
18,910
-8,380
-31% -$61.4K ﹤0.01% 5003
2025
Q3 		$241K Buy
27,290
+19,220
+238% +$170K ﹤0.01% 4482
2025
Q2 		$56.3K Buy
+8,070
New +$74.1K ﹤0.01% 5488
2025
Q1 		– Sell
-2,640
Closed -$26.4K – 7940
2024
Q4 		$26.4K Sell
2,640
-3,260
-55% -$41.1K ﹤0.01% 5515
2024
Q3 		$97.3K Buy
5,900
+1,850
+46% +$26.3K ﹤0.01% 4205
2024
Q2 		$45K Buy
4,050
+280
+7% +$3.48K ﹤0.01% 4598
2024
Q1 		$49.8K Sell
3,770
-7,000
-65% -$91K ﹤0.01% 4731
2023
Q4 		$162K Buy
10,770
+3,070
+40% +$37.6K ﹤0.01% 4052
2023
Q3 		$113K Buy
7,700
+1,300
+20% +$25K ﹤0.01% 4338
2023
Q2 		$161K Buy
6,400
+4,210
+192% +$70.6K ﹤0.01% 4162
2023
Q1 		$32.6K Sell
2,190
-17,880
-89% -$332K ﹤0.01% 5182
2022
Q4 		$281K Buy
20,070
+17,890
+821% +$488K ﹤0.01% 3556
2022
Q3 		$69K Sell
2,180
-1,960
-47% -$82K ﹤0.01% 5127
2022
Q2 		$144K Sell
4,140
-590
-12% -$37.8K ﹤0.01% 4629
2022
Q1 		$534K Buy
4,730
+4,700
+15,667% +$544K ﹤0.01% 3735
2021
Q4 		$3K Sell
30
-80
-73% -$7.21K ﹤0.01% 7786
2021
Q3 		$10K Sell
110
-870
-89% -$85.6K ﹤0.01% 7497
2021
Q2 		$120K Sell
980
-110
-10% -$15.2K ﹤0.01% 5776
2021
Q1 		$174K Sell
1,090
-390
-26% -$66.2K ﹤0.01% 5164
2020
Q4 		$226K Buy
1,480
+770
+108% +$138K ﹤0.01% 3971
2020
Q3 		$132K Buy
+710
New +$116K ﹤0.01% 3979
2020
Q1 		– Sell
-16,550
Closed -$1.6M – 5484
2019
Q4 		$1.6M Hold
16,550
– – 0.01% 1471
2019
Q3 		$1.67M Sell
16,550
-8,600
-34% -$1.15M 0.01% 1346
2019
Q2 		$2.88M Buy
25,150
+24,782
+6,734% +$3.26M 0.03% 840
2019
Q1 		$29K Sell
368
-11
-3% -$966 ﹤0.01% 3857
2018
Q4 		$28K Buy
379
+361
+2,006% +$42.3K ﹤0.01% 3858
2018
Q3 		$2K Buy
18
+9
+100% +$23.5K ﹤0.01% 5015
2018
Q2 		$24K Buy
+9
New +$20.8K ﹤0.01% 4305
2018
Q1 		– Sell
-4
Closed -$9K – 5048
2017
Q4 		$9K Hold
4
– – ﹤0.01% 4404
2017
Q3 		$8K Buy
+4
New +$5.22K ﹤0.01% 4353
2017
Q2 		– Sell
-63
Closed -$100K – 4894
2017
Q1 		$100K Buy
63
+4
+7% +$7.32K ﹤0.01% 2979
2016
Q4 		$103K Sell
59
-1
-2% -$2.19K ﹤0.01% 2831
2016
Q3 		$146K Buy
60
+9
+18% +$22.2K ﹤0.01% 2688
2016
Q2 		$126K Sell
51
-243
-83% -$798K ﹤0.01% 2700
2016
Q1 		$1.06M Buy
294
+10
+4% +$34.7K 0.02% 1130
2015
Q4 		$1.31M Sell
284
-1,337
-82% -$4.36M 0.02% 1130
2015
Q3 		$2.62M Buy
1,621
+1,610
+14,636% +$8.05M 0.04% 626
2015
Q2 		$95K Buy
11
+8
+267% +$76.3K ﹤0.01% 3128
2015
Q1 		$33K Buy
+3
New +$27.6K ﹤0.01% 3610

Other funds holding IMUX

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Group One Trading's IMUX Position: Q1 2026 in Review

Group One Trading opened a new position in Immunic (IMUX) in Q1 2026: 170 shares worth $1.89K. The stake represents ﹤0.01% of the portfolio and ranks #7071 among its holdings. This is a return to the name: Group One Trading previously reported a position in IMUX as recently as Q2 2025.

Group One Trading first reported a position in IMUX in Q1 2015 and has held it in 27 quarters since. The position peaked at $203K in Q1 2022. 75 funds tracked by Wall St. Rank hold IMUX as of Q1 2026.

  • Group One Trading held 170 shares of Immunic worth $1.89K as of Q1 2026.
  • Immunic was a new Group One Trading position in Q1 2026.
  • Immunic made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7071 holding.
  • Group One Trading first reported a position in Immunic in Q1 2015 and has held it in 27 quarters since.
  • Group One Trading's Immunic position peaked at $203K in Q1 2022.
  • 75 funds tracked by Wall St. Rank held Immunic as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.